An overall model of cancer‐specific survival adjusted for age and stage showed an interaction between mucin status and tumor anatomic site; patients with MCAs and rectal tumors had a 2.1 times greater hazard of death from CRC (CI = 1.2–3.8), independent of age, stage, gender, and race (data not shown). The gene discussed is MUC5AC; the disease is cancer.